Concepedia

Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer

Jennifer R. Diamond, Carlos Becerra, Donald Richards, Alain C. Mita, Cynthia R. Osborne, Joyce O’Shaughnessy, Chun Zhang, Randall Henner, Ann M. Kapoun, Lu Xu,

Breast Cancer Research and Treatment · 2020 · 149 citations · 12 references

DOIFull text

Open access

Concepts

References

12

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +12

Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer

Kathy D. Miller, Molin Wang, Julie R. Gralow et al. · New England Journal of Medicine · 2007 · 3.1K citations · Full text

, , +13

3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

Fátima Cardoso, A. Costa, Elżbieta Senkus et al. · Annals of Oncology · 2016 · 2.1K citations · Full text

, , +11

4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)

Fátima Cardoso, Elżbieta Senkus, A. Costa et al. · Annals of Oncology · 2018 · 1.2K citations · Full text

, , +16

<i>Cbfa1</i>-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor

Masaki Kato, Millan S. Patel, Régis Levasseur et al. · The Journal of Cell Biology · 2002 · 1.1K citations · Full text

, , +17